Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

NCT05540665 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Lupus Nephritis

Interventions

DRUG: Daxdilimab
DRUG: Daxdilimab
DRUG: Placebo (Normal Saline)

Sponsor

Amgen